Rafael Holdings Reports Second Quarter Fiscal 2024 Financial

13.03.2024 - Company remains focused on generating shareholder value by advancing portfolio and identifying attractive opportunities for strategic investments Increased ownership in Day Three Labs to a majority interest of 79% NEWARK, N.J., March 13, 2024 ...

Related Keywords

Barbara Ryan , John Goldberg , Nasdaq , Rafael Medical Devices , Cornerstone Pharmaceuticals Inc , Rafael Pharmaceuticals Inc , Barer Institute Inc , Lipomedix Pharmaceuticals Ltd , Rafael Holdings , Day Three Labs Inc , Cyclo Therapeutics Inc , Rafael Holdings Inc , Other Pharmaceuticals , Barer Institute , Chief Medical , Bill Conkling , Cyclo Therapeutic , Day Three Labs , Second Quarter Fiscal Year , Cyclo Therapeutics , Day Three , First Half Fiscal Year , Cornerstone Pharmaceuticals , Institute Inc , Trappsol Cyclo , Private Securities Litigation Reform Act , Annual Report , Hedge Funds , Months Ended January , Therapeutics Inc , Rafael Holdings Registeredb Chart , Afael Holdings Registeredb Kurs , Afael Holdings Registeredb Aktie ,